ESR2 and colonic neoplasm: Cai et al. found that equol can inhibit the growth of colon cancer cells HCT-15 (expressing both ERα and ERβ), LOVO, and SW480 (expressing only ERβ) by upregulating the expression of Nrf2, a key factor involved in antioxidant effects, in vitro [106].